Standardized Treatment of Neonatal Status Epilepticus Improves Outcome

Mandy L Harris1, Katherine M Malloy2, Sheena N Lawson3

  • 1Department of Neurology, Division of Child Neurology, Indiana University, School of Medicine, Indianapolis, IN, USA.

Journal of Child Neurology
|September 2, 2016
PubMed

Insights

Implementing a standardized protocol for neonatal status epilepticus treatment improved outcomes and consistency. Adherence was partially achieved, but significant improvements were seen in phenobarbital levels, seizure progression, and hospital stay.

Area of Science:

  • Neonatal Neurology
  • Pediatric Critical Care
  • Clinical Protocol Implementation

Background:

  • Neonatal status epilepticus (NSE) treatment often lacks standardization, leading to practice variation.
  • Varied treatment approaches can impact patient outcomes and resource utilization.

Purpose of the Study:

  • To reduce practice variation in treating neonatal status epilepticus through a standardized protocol.
  • To assess the impact of a standardized protocol on adherence, serum phenobarbital levels, seizure progression, and hospital length of stay.

Main Methods:

  • A standardized treatment protocol for NSE was implemented.
  • Data on adherence, serum phenobarbital concentrations, seizure progression, and hospital length of stay were collected for 6 months prior and 12 months post-implementation.

Main Results:

  • Protocol adherence was partially achieved (target 80%) in the overall cohort but not in pretreated patients.
  • Significant reductions were observed in maximum serum phenobarbital concentrations (56.8 vs 41.0 µg/mL).
  • Fewer patients progressed from seizures to status epilepticus (46% vs 36%), and hospital length of stay decreased by 9.7 days in survivors.

Conclusions:

  • Standardized, protocol-driven treatment of neonatal status epilepticus enhances treatment consistency.
  • Implementation of the protocol led to improved short-term outcomes for neonates with status epilepticus.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.8K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K